 | • レポートコード：QFJ1-4024 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、臨床バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断バイオマーカー、予測バイオマーカー、予後バイオマーカー）、用途別市場規模（研究所、バイオ医薬品・バイオテクノロジー企業、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・臨床バイオマーカーの市場動向 ・企業の競争状況、市場シェア ・臨床バイオマーカーの種類別市場規模と予測2016-2027（診断バイオマーカー、予測バイオマーカー、予後バイオマーカー） ・臨床バイオマーカーの用途別市場規模と予測2016-2027（研究所、バイオ医薬品・バイオテクノロジー企業、診断センター、その他） ・臨床バイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・臨床バイオマーカーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・臨床バイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・臨床バイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・臨床バイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Agilent Technologies, Inc.、ALCEDIAG、Becton, Dickinson and Company、bioMérieux S.A.、Bio-Rad Laboratories, Inc.、CENTOGENE N.V.、F. Hoffmann-La Roche Ltd.、Enzo Biochem Inc.、Illumina, Inc.、Myriad Genetics, Inc.、Quest Diagnostics Incorporated、QIAGEN N.V.、Thermo Fisher Scientific Inc.） ・結論 |
Biomarkers are a class of markers related to cell growth and proliferation that have been proposed in recent years with the development of immunology and molecular biology techniques. Biomarkers can not only discuss the pathogenesis at the molecular level, but also have a unique advantage in accurately and sensitively evaluating early and low-level damage. They can provide early warning, which largely provides clinicians with auxiliary diagnosis Basis.
Market Analysis and Insights: Global Clinical Biomarkers Market
The global Clinical Biomarkers market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Biomarkers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Biomarkers market.
Global Clinical Biomarkers Scope and Market Size
Clinical Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diagnostic Biomarkers
Predictive Biomarkers
Prognostic Biomarkers
Segment by Application
Research and Academic Laboratories
Biopharmaceutical and Biotech Companies
Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
Agilent Technologies, Inc.
ALCEDIAG
Becton, Dickinson and Company
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
CENTOGENE N.V.
F. Hoffmann-La Roche Ltd.
Enzo Biochem Inc.
Illumina, Inc.
Myriad Genetics, Inc.
Quest Diagnostics Incorporated
QIAGEN N.V.
Thermo Fisher Scientific Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Biomarkers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnostic Biomarkers
1.2.3 Predictive Biomarkers
1.2.4 Prognostic Biomarkers
1.3 Market by Application
1.3.1 Global Clinical Biomarkers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research and Academic Laboratories
1.3.3 Biopharmaceutical and Biotech Companies
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Biomarkers Market Perspective (2016-2027)
2.2 Clinical Biomarkers Growth Trends by Regions
2.2.1 Clinical Biomarkers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Clinical Biomarkers Historic Market Share by Regions (2016-2021)
2.2.3 Clinical Biomarkers Forecasted Market Size by Regions (2022-2027)
2.3 Clinical Biomarkers Industry Dynamic
2.3.1 Clinical Biomarkers Market Trends
2.3.2 Clinical Biomarkers Market Drivers
2.3.3 Clinical Biomarkers Market Challenges
2.3.4 Clinical Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Biomarkers Players by Revenue
3.1.1 Global Top Clinical Biomarkers Players by Revenue (2016-2021)
3.1.2 Global Clinical Biomarkers Revenue Market Share by Players (2016-2021)
3.2 Global Clinical Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Clinical Biomarkers Revenue
3.4 Global Clinical Biomarkers Market Concentration Ratio
3.4.1 Global Clinical Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Biomarkers Revenue in 2020
3.5 Clinical Biomarkers Key Players Head office and Area Served
3.6 Key Players Clinical Biomarkers Product Solution and Service
3.7 Date of Enter into Clinical Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Biomarkers Breakdown Data by Type
4.1 Global Clinical Biomarkers Historic Market Size by Type (2016-2021)
4.2 Global Clinical Biomarkers Forecasted Market Size by Type (2022-2027)
5 Clinical Biomarkers Breakdown Data by Application
5.1 Global Clinical Biomarkers Historic Market Size by Application (2016-2021)
5.2 Global Clinical Biomarkers Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Clinical Biomarkers Market Size (2016-2027)
6.2 North America Clinical Biomarkers Market Size by Type
6.2.1 North America Clinical Biomarkers Market Size by Type (2016-2021)
6.2.2 North America Clinical Biomarkers Market Size by Type (2022-2027)
6.2.3 North America Clinical Biomarkers Market Size by Type (2016-2027)
6.3 North America Clinical Biomarkers Market Size by Application
6.3.1 North America Clinical Biomarkers Market Size by Application (2016-2021)
6.3.2 North America Clinical Biomarkers Market Size by Application (2022-2027)
6.3.3 North America Clinical Biomarkers Market Size by Application (2016-2027)
6.4 North America Clinical Biomarkers Market Size by Country
6.4.1 North America Clinical Biomarkers Market Size by Country (2016-2021)
6.4.2 North America Clinical Biomarkers Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Biomarkers Market Size (2016-2027)
7.2 Europe Clinical Biomarkers Market Size by Type
7.2.1 Europe Clinical Biomarkers Market Size by Type (2016-2021)
7.2.2 Europe Clinical Biomarkers Market Size by Type (2022-2027)
7.2.3 Europe Clinical Biomarkers Market Size by Type (2016-2027)
7.3 Europe Clinical Biomarkers Market Size by Application
7.3.1 Europe Clinical Biomarkers Market Size by Application (2016-2021)
7.3.2 Europe Clinical Biomarkers Market Size by Application (2022-2027)
7.3.3 Europe Clinical Biomarkers Market Size by Application (2016-2027)
7.4 Europe Clinical Biomarkers Market Size by Country
7.4.1 Europe Clinical Biomarkers Market Size by Country (2016-2021)
7.4.2 Europe Clinical Biomarkers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Clinical Biomarkers Market Size (2016-2027)
8.2 Asia-Pacific Clinical Biomarkers Market Size by Type
8.2.1 Asia-Pacific Clinical Biomarkers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Clinical Biomarkers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Clinical Biomarkers Market Size by Type (2016-2027)
8.3 Asia-Pacific Clinical Biomarkers Market Size by Application
8.3.1 Asia-Pacific Clinical Biomarkers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Clinical Biomarkers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Clinical Biomarkers Market Size by Application (2016-2027)
8.4 Asia-Pacific Clinical Biomarkers Market Size by Region
8.4.1 Asia-Pacific Clinical Biomarkers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Clinical Biomarkers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical Biomarkers Market Size (2016-2027)
9.2 Latin America Clinical Biomarkers Market Size by Type
9.2.1 Latin America Clinical Biomarkers Market Size by Type (2016-2021)
9.2.2 Latin America Clinical Biomarkers Market Size by Type (2022-2027)
9.2.3 Latin America Clinical Biomarkers Market Size by Type (2016-2027)
9.3 Latin America Clinical Biomarkers Market Size by Application
9.3.1 Latin America Clinical Biomarkers Market Size by Application (2016-2021)
9.3.2 Latin America Clinical Biomarkers Market Size by Application (2022-2027)
9.3.3 Latin America Clinical Biomarkers Market Size by Application (2016-2027)
9.4 Latin America Clinical Biomarkers Market Size by Country
9.4.1 Latin America Clinical Biomarkers Market Size by Country (2016-2021)
9.4.2 Latin America Clinical Biomarkers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Biomarkers Market Size (2016-2027)
10.2 Middle East & Africa Clinical Biomarkers Market Size by Type
10.2.1 Middle East & Africa Clinical Biomarkers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Clinical Biomarkers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Clinical Biomarkers Market Size by Type (2016-2027)
10.3 Middle East & Africa Clinical Biomarkers Market Size by Application
10.3.1 Middle East & Africa Clinical Biomarkers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Clinical Biomarkers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Clinical Biomarkers Market Size by Application (2016-2027)
10.4 Middle East & Africa Clinical Biomarkers Market Size by Country
10.4.1 Middle East & Africa Clinical Biomarkers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Clinical Biomarkers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Clinical Biomarkers Introduction
11.1.4 Abbott Laboratories Revenue in Clinical Biomarkers Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Details
11.2.2 Agilent Technologies, Inc. Business Overview
11.2.3 Agilent Technologies, Inc. Clinical Biomarkers Introduction
11.2.4 Agilent Technologies, Inc. Revenue in Clinical Biomarkers Business (2016-2021)
11.2.5 Agilent Technologies, Inc. Recent Development
11.3 ALCEDIAG
11.3.1 ALCEDIAG Company Details
11.3.2 ALCEDIAG Business Overview
11.3.3 ALCEDIAG Clinical Biomarkers Introduction
11.3.4 ALCEDIAG Revenue in Clinical Biomarkers Business (2016-2021)
11.3.5 ALCEDIAG Recent Development
11.4 Becton, Dickinson and Company
11.4.1 Becton, Dickinson and Company Company Details
11.4.2 Becton, Dickinson and Company Business Overview
11.4.3 Becton, Dickinson and Company Clinical Biomarkers Introduction
11.4.4 Becton, Dickinson and Company Revenue in Clinical Biomarkers Business (2016-2021)
11.4.5 Becton, Dickinson and Company Recent Development
11.5 bioMérieux S.A.
11.5.1 bioMérieux S.A. Company Details
11.5.2 bioMérieux S.A. Business Overview
11.5.3 bioMérieux S.A. Clinical Biomarkers Introduction
11.5.4 bioMérieux S.A. Revenue in Clinical Biomarkers Business (2016-2021)
11.5.5 bioMérieux S.A. Recent Development
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Bio-Rad Laboratories, Inc. Company Details
11.6.2 Bio-Rad Laboratories, Inc. Business Overview
11.6.3 Bio-Rad Laboratories, Inc. Clinical Biomarkers Introduction
11.6.4 Bio-Rad Laboratories, Inc. Revenue in Clinical Biomarkers Business (2016-2021)
11.6.5 Bio-Rad Laboratories, Inc. Recent Development
11.7 CENTOGENE N.V.
11.7.1 CENTOGENE N.V. Company Details
11.7.2 CENTOGENE N.V. Business Overview
11.7.3 CENTOGENE N.V. Clinical Biomarkers Introduction
11.7.4 CENTOGENE N.V. Revenue in Clinical Biomarkers Business (2016-2021)
11.7.5 CENTOGENE N.V. Recent Development
11.8 F. Hoffmann-La Roche Ltd.
11.8.1 F. Hoffmann-La Roche Ltd. Company Details
11.8.2 F. Hoffmann-La Roche Ltd. Business Overview
11.8.3 F. Hoffmann-La Roche Ltd. Clinical Biomarkers Introduction
11.8.4 F. Hoffmann-La Roche Ltd. Revenue in Clinical Biomarkers Business (2016-2021)
11.8.5 F. Hoffmann-La Roche Ltd. Recent Development
11.9 Enzo Biochem Inc.
11.9.1 Enzo Biochem Inc. Company Details
11.9.2 Enzo Biochem Inc. Business Overview
11.9.3 Enzo Biochem Inc. Clinical Biomarkers Introduction
11.9.4 Enzo Biochem Inc. Revenue in Clinical Biomarkers Business (2016-2021)
11.9.5 Enzo Biochem Inc. Recent Development
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Details
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Clinical Biomarkers Introduction
11.10.4 Illumina, Inc. Revenue in Clinical Biomarkers Business (2016-2021)
11.10.5 Illumina, Inc. Recent Development
11.11 Myriad Genetics, Inc.
11.11.1 Myriad Genetics, Inc. Company Details
11.11.2 Myriad Genetics, Inc. Business Overview
11.11.3 Myriad Genetics, Inc. Clinical Biomarkers Introduction
11.11.4 Myriad Genetics, Inc. Revenue in Clinical Biomarkers Business (2016-2021)
11.11.5 Myriad Genetics, Inc. Recent Development
11.12 Quest Diagnostics Incorporated
11.12.1 Quest Diagnostics Incorporated Company Details
11.12.2 Quest Diagnostics Incorporated Business Overview
11.12.3 Quest Diagnostics Incorporated Clinical Biomarkers Introduction
11.12.4 Quest Diagnostics Incorporated Revenue in Clinical Biomarkers Business (2016-2021)
11.12.5 Quest Diagnostics Incorporated Recent Development
11.13 QIAGEN N.V.
11.13.1 QIAGEN N.V. Company Details
11.13.2 QIAGEN N.V. Business Overview
11.13.3 QIAGEN N.V. Clinical Biomarkers Introduction
11.13.4 QIAGEN N.V. Revenue in Clinical Biomarkers Business (2016-2021)
11.13.5 QIAGEN N.V. Recent Development
11.14 Thermo Fisher Scientific Inc.
11.14.1 Thermo Fisher Scientific Inc. Company Details
11.14.2 Thermo Fisher Scientific Inc. Business Overview
11.14.3 Thermo Fisher Scientific Inc. Clinical Biomarkers Introduction
11.14.4 Thermo Fisher Scientific Inc. Revenue in Clinical Biomarkers Business (2016-2021)
11.14.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Clinical Biomarkers Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnostic Biomarkers
Table 3. Key Players of Predictive Biomarkers
Table 4. Key Players of Prognostic Biomarkers
Table 5. Global Clinical Biomarkers Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Clinical Biomarkers Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Clinical Biomarkers Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Clinical Biomarkers Market Share by Regions (2016-2021)
Table 9. Global Clinical Biomarkers Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Clinical Biomarkers Market Share by Regions (2022-2027)
Table 11. Clinical Biomarkers Market Trends
Table 12. Clinical Biomarkers Market Drivers
Table 13. Clinical Biomarkers Market Challenges
Table 14. Clinical Biomarkers Market Restraints
Table 15. Global Clinical Biomarkers Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Clinical Biomarkers Market Share by Players (2016-2021)
Table 17. Global Top Clinical Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Biomarkers as of 2020)
Table 18. Ranking of Global Top Clinical Biomarkers Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Clinical Biomarkers Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Clinical Biomarkers Product Solution and Service
Table 22. Date of Enter into Clinical Biomarkers Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Clinical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Clinical Biomarkers Revenue Market Share by Type (2016-2021)
Table 26. Global Clinical Biomarkers Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Clinical Biomarkers Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Clinical Biomarkers Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Clinical Biomarkers Revenue Market Share by Application (2016-2021)
Table 30. Global Clinical Biomarkers Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Clinical Biomarkers Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Clinical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Clinical Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Clinical Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Clinical Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Clinical Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Clinical Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Clinical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Clinical Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Clinical Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Clinical Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Clinical Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Clinical Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Clinical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Clinical Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Clinical Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Clinical Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Clinical Biomarkers Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Clinical Biomarkers Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Clinical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Clinical Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Clinical Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Clinical Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Clinical Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Clinical Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Clinical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Clinical Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Clinical Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Clinical Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Clinical Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Clinical Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Clinical Biomarkers Product
Table 65. Abbott Laboratories Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 66. Abbott Laboratories Recent Development
Table 67. Agilent Technologies, Inc. Company Details
Table 68. Agilent Technologies, Inc. Business Overview
Table 69. Agilent Technologies, Inc. Clinical Biomarkers Product
Table 70. Agilent Technologies, Inc. Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 71. Agilent Technologies, Inc. Recent Development
Table 72. ALCEDIAG Company Details
Table 73. ALCEDIAG Business Overview
Table 74. ALCEDIAG Clinical Biomarkers Product
Table 75. ALCEDIAG Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 76. ALCEDIAG Recent Development
Table 77. Becton, Dickinson and Company Company Details
Table 78. Becton, Dickinson and Company Business Overview
Table 79. Becton, Dickinson and Company Clinical Biomarkers Product
Table 80. Becton, Dickinson and Company Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 81. Becton, Dickinson and Company Recent Development
Table 82. bioMérieux S.A. Company Details
Table 83. bioMérieux S.A. Business Overview
Table 84. bioMérieux S.A. Clinical Biomarkers Product
Table 85. bioMérieux S.A. Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 86. bioMérieux S.A. Recent Development
Table 87. Bio-Rad Laboratories, Inc. Company Details
Table 88. Bio-Rad Laboratories, Inc. Business Overview
Table 89. Bio-Rad Laboratories, Inc. Clinical Biomarkers Product
Table 90. Bio-Rad Laboratories, Inc. Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 91. Bio-Rad Laboratories, Inc. Recent Development
Table 92. CENTOGENE N.V. Company Details
Table 93. CENTOGENE N.V. Business Overview
Table 94. CENTOGENE N.V. Clinical Biomarkers Product
Table 95. CENTOGENE N.V. Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 96. CENTOGENE N.V. Recent Development
Table 97. F. Hoffmann-La Roche Ltd. Company Details
Table 98. F. Hoffmann-La Roche Ltd. Business Overview
Table 99. F. Hoffmann-La Roche Ltd. Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 100. F. Hoffmann-La Roche Ltd. Recent Development
Table 101. Enzo Biochem Inc. Company Details
Table 102. Enzo Biochem Inc. Business Overview
Table 103. Enzo Biochem Inc. Clinical Biomarkers Product
Table 104. Enzo Biochem Inc. Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 105. Enzo Biochem Inc. Recent Development
Table 106. Illumina, Inc. Company Details
Table 107. Illumina, Inc. Business Overview
Table 108. Illumina, Inc. Clinical Biomarkers Product
Table 109. Illumina, Inc. Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 110. Illumina, Inc. Recent Development
Table 111. Myriad Genetics, Inc. Company Details
Table 112. Myriad Genetics, Inc. Business Overview
Table 113. Myriad Genetics, Inc. Clinical Biomarkers Product
Table 114. Myriad Genetics, Inc. Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 115. Myriad Genetics, Inc. Recent Development
Table 116. Quest Diagnostics Incorporated Company Details
Table 117. Quest Diagnostics Incorporated Business Overview
Table 118. Quest Diagnostics Incorporated Clinical Biomarkers Product
Table 119. Quest Diagnostics Incorporated Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 120. Quest Diagnostics Incorporated Recent Development
Table 121. QIAGEN N.V. Company Details
Table 122. QIAGEN N.V. Business Overview
Table 123. QIAGEN N.V. Clinical Biomarkers Product
Table 124. QIAGEN N.V. Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 125. QIAGEN N.V. Recent Development
Table 126. Thermo Fisher Scientific Inc. Company Details
Table 127. Thermo Fisher Scientific Inc. Business Overview
Table 128. Thermo Fisher Scientific Inc. Clinical Biomarkers Product
Table 129. Thermo Fisher Scientific Inc. Revenue in Clinical Biomarkers Business (2016-2021) & (US$ Million)
Table 130. Thermo Fisher Scientific Inc. Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Biomarkers Market Share by Type: 2020 VS 2027
Figure 2. Diagnostic Biomarkers Features
Figure 3. Predictive Biomarkers Features
Figure 4. Prognostic Biomarkers Features
Figure 5. Global Clinical Biomarkers Market Share by Application: 2020 VS 2027
Figure 6. Research and Academic Laboratories Case Studies
Figure 7. Biopharmaceutical and Biotech Companies Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Clinical Biomarkers Report Years Considered
Figure 11. Global Clinical Biomarkers Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Clinical Biomarkers Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Clinical Biomarkers Market Share by Regions: 2020 VS 2027
Figure 14. Global Clinical Biomarkers Market Share by Regions (2022-2027)
Figure 15. Global Clinical Biomarkers Market Share by Players in 2020
Figure 16. Global Top Clinical Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Biomarkers as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Clinical Biomarkers Revenue in 2020
Figure 18. Global Clinical Biomarkers Revenue Market Share by Type (2016-2021)
Figure 19. Global Clinical Biomarkers Revenue Market Share by Type (2022-2027)
Figure 20. North America Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Clinical Biomarkers Market Share by Type (2016-2027)
Figure 22. North America Clinical Biomarkers Market Share by Application (2016-2027)
Figure 23. North America Clinical Biomarkers Market Share by Country (2016-2027)
Figure 24. United States Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Clinical Biomarkers Market Share by Type (2016-2027)
Figure 28. Europe Clinical Biomarkers Market Share by Application (2016-2027)
Figure 29. Europe Clinical Biomarkers Market Share by Country (2016-2027)
Figure 30. Germany Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Clinical Biomarkers Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Clinical Biomarkers Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Clinical Biomarkers Market Share by Region (2016-2027)
Figure 40. China Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Clinical Biomarkers Market Share by Type (2016-2027)
Figure 48. Latin America Clinical Biomarkers Market Share by Application (2016-2027)
Figure 49. Latin America Clinical Biomarkers Market Share by Country (2016-2027)
Figure 50. Mexico Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Clinical Biomarkers Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Clinical Biomarkers Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Clinical Biomarkers Market Share by Country (2016-2027)
Figure 56. Turkey Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Clinical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 60. Agilent Technologies, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 61. ALCEDIAG Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 62. Becton, Dickinson and Company Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 63. bioMérieux S.A. Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 64. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 65. CENTOGENE N.V. Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 66. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 67. Enzo Biochem Inc. Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 68. Illumina, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 69. Myriad Genetics, Inc. Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 70. Quest Diagnostics Incorporated Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 71. QIAGEN N.V. Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 72. Thermo Fisher Scientific Inc. Revenue Growth Rate in Clinical Biomarkers Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の診断バイオマーカー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diagnostic Biomarkers Market The global Diagnostic Biomarkers market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…- 世界の心臓バイオマーカー検査市場規模・現状・予測（2021年-2027年） Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and car…
- 神経バイオマーカーのグローバル市場2021 A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood gluco…
- NASH（非アルコール性脂肪性肝炎）バイオマーカーのグローバル市場調査 2019年 The global NASH (Non-alcoholic Steatohepatitis) Biomarkers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on NASH (Non-alcoholic Steatohepatitis) Biomarkers volume and value at global level, regional …
- 商用バイオマーカーのグローバル市場調査 2019年 The global Commercializing Biomarkers market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Commercializing Biomarkers volume and value at global level, regional level and company level. From a global per…